9ZS4 image
Deposition Date 2025-12-22
Release Date 2026-05-13
Last Version Date 2026-11-11
Entry Detail
PDB ID:
9ZS4
Title:
S. marcescens Cas10-Csm bound to target RNA
Biological Source:
Source Organism(s):
Serratia (Taxon ID: 613)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CRISPR system single-strand-s
Gene (Uniprot):cas10
Chain IDs:A
Chain Length:816
Number of Molecules:1
Biological Source:Serratia
Polymer Type:polypeptide(L)
Molecule:CRISPR system Cms protein Csm
Gene (Uniprot):csm2
Chain IDs:D (auth: B), E (auth: C), F (auth: D)
Chain Length:133
Number of Molecules:3
Biological Source:Serratia
Polymer Type:polypeptide(L)
Molecule:CRISPR system Cms endoribonuc
Gene (Uniprot):csm3
Mutagens:D34A
Chain IDs:G (auth: E), H (auth: F), I (auth: G), J (auth: H)
Chain Length:248
Number of Molecules:4
Biological Source:Serratia
Polymer Type:polypeptide(L)
Molecule:CRISPR system Cms protein Csm
Gene (Uniprot):CWC46_19915, Ser39006_019910
Chain IDs:K (auth: I)
Chain Length:326
Number of Molecules:1
Biological Source:Serratia
Polymer Type:polypeptide(L)
Molecule:CRISPR system Cms protein Csm
Gene (Uniprot):CWC46_19920, Ser39006_019915
Chain IDs:L (auth: J)
Chain Length:559
Number of Molecules:1
Biological Source:Serratia
Polymer Type:polyribonucleotide
Molecule:crRNA
Chain IDs:B (auth: K)
Chain Length:42
Number of Molecules:1
Biological Source:Serratia
Polymer Type:polyribonucleotide
Molecule:Target RNA
Chain IDs:C (auth: L)
Chain Length:42
Number of Molecules:1
Biological Source:Serratia
Ligand Molecules
Primary Citation
Structural insights into target detection by the Serratia type III CRISPR complex and its deployment in SNP identifications.
J.Biol.Chem. 302 113595 113595 (2026)
PMID: 42772556 DOI: 10.1016/j.jbc.2026.113595

Abstact

Type III CRISPR systems utilize a complex containing Cas10, additional Cas proteins and a crRNA to detect foreign transcripts. Upon detection, Cas10 synthesizes cyclic oligoadenylates (cOA), signaling molecules that coordinate interference by stimulating downstream enzymes with DNase, RNase, protease or other activities. Type III systems possess properties well-suited to their deployment as molecular diagnostics: specific detection and activation of a cascade of multi-turnover enzymatic reactions that can be harnessed for signal generation. We answered key questions concerning the structure and function of Serratia Cas10-Csm to facilitate its use in molecular diagnostics. We determined that Serratia Cas10-Csm (SerrCas10-Csm) synthesizes predominantly cA(3) molecules and this synthesis is sensitive to mismatches in the crRNA-target RNA duplex adjacent to Cas10. To understand how Cas10 senses the presence of a bound target RNA, we determined the structure of SerrCas10-Csm unbound and bound to target RNA identifying conformational changes associated with target binding. We programmed SerrCas10-Csm with a crRNA recognizing a single nucleotide polymorphism that occurs in the human HBB transcript and is associated with sickle cell disease. We demonstrate that when the polymorphism occurs in the +1 position of the crRNA-target duplex, SerrCas10-Csm can distinguish it indicating an additional role for type III CRISPR systems in point-of-care diagnostics in low-resource settings.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback